Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1999-1-29
pubmed:abstractText
For over three decades, scientists in a number of different laboratories have worked to design peptide analogues of oxytocin (OT) selective for the oxytocin receptor. Although there has been some interest in their use for treatment of dysmenorrhea, the principal clinical venue for such agents has been thought to lie in treatment of preterm labor. A major difficulty in identifying the clinical role for an OT antagonist had been our incomplete understanding of the role of OT in both term and preterm labor. This article begins with a review of the current understanding of the role of OT in the initiation and maintenance of labor in the human.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0095-5108
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
859-71, vi
pubmed:dateRevised
2008-9-3
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Oxytocin receptor antagonists. Update.
pubmed:affiliation
Department of Obstetrics and Gynecology, University of Southern California, Women's and Children's Hospital, Los Angeles, USA. tgoodwin@hsc.usc.edu
pubmed:publicationType
Journal Article, Review